Gemma Llovera

Gemma Llovera

Auto-generated profile, based on publicly available information

Gemma Llovera

Institute for Stroke and Dementia Research, LMU Munich

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2016 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
VSVikramjeet Singh
Vikramjeet Singh
SRStefan Roth
Stefan Roth
GLGemma Llovera
Gemma Llovera
RSRebecca Sadler
Rebecca Sadler
DGDebora Garzetti
Debora Garzetti
ALArthur Liesz
Arthur Liesz
Acute brain ischemia induces a local neuroinflammatory reaction and alters peripheral immune homeostasis at the same time. Recent evidence has suggested a key role of the gut microbiota in autoimmune diseases by modulating immune homeostasis. Therefore, we investigated the mechanistic link among acute brain ischemia, microbiota alterations, and the immune response after brain injury. Using two distinct models of acute middle cerebral artery occlusion, we show by next-generation sequencing that large stroke lesions cause gut microbiota dysbiosis, which in turn affects stroke outcome via immune-mediated mechanisms. Reduced species diversity and bacterial overgrowth of bacteroidetes were identified as hallmarks of poststroke dysbiosis, which was associated with intestinal barrier dysfunction and reduced intestinal motility as determined by in vivo intestinal bolus tracking. Recolonizing germ-free mice with dysbiotic poststroke microbiota exacerbates lesion volume and functional deficits after experimental stroke compared with the recolonization with a normal control microbiota. In addition, recolonization of mice with a dysbiotic microbiome induces a proinflammatory T-cell polarization in the intestinal immune compartment and in the ischemic brain. Using in vivo cell-tracking studies, we demonstrate the migration of intestinal lymphocytes to the ischemic brain. Therapeutic transplantation of fecal microbiota normalizes brain lesion-induced dysbiosis and improves stroke outcome. These results support a novel mechanism in which the gut microbiome is a target of stroke-induced systemic alterations and an effector with substantial impact on stroke outcome.

5 August 2015 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
GLGemma Llovera
Gemma Llovera
KHKerstin Hofmann
Kerstin Hofmann
SRStefan Roth
Stefan Roth
ASAngelica Salas-Pérdomo
Angelica Salas-Pérdomo
MFMaura Ferrer-Ferrer
Maura Ferrer-Ferrer
ALArthur Liesz
Arthur Liesz
A multicenter preclinical, randomized, controlled trial (pRCT) of a potential stroke treatment in mice demonstrates the feasibility of performing clinical trial–like investigations in animal models.

21 December 2016 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
ADAnna Daria
Anna Daria
ACAlessio Colombo
Alessio Colombo
GLGemma Llovera
Gemma Llovera
HHHeike Hampel
Heike Hampel
MWMichael Willem
Michael Willem
STSabina Tahirovic
Sabina Tahirovic

31 July 2017 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
GLGemma Llovera
Gemma Llovera
CBCorinne Benakis
Corinne Benakis
GEGaby Enzmann
Gaby Enzmann
RCRuiyao Cai
Ruiyao Cai
TAThomas Arzberger
Thomas Arzberger
ALArthur Liesz
Arthur Liesz

21 September 2016 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
AEAli Ertürk
Ali Ertürk
SMSusanne Mentz
Susanne Mentz
ESErik E. Stout
Erik E. Stout
MHMaj Hedehus
Maj Hedehus
SDSara L. Dominguez
Sara L. Dominguez
MSMorgan Sheng
Morgan Sheng
After traumatic brain injury (TBI), neurons surviving the initial insult can undergo chronic (secondary) degeneration via poorly understood mechanisms, resulting in long-term cognitive impairment. Although a neuroinflammatory response is promptly activated after TBI, it is unknown whether it has a significant role in chronic phases of TBI (>1 year after injury). Using a closed-head injury model of TBI in mice, we showed by MRI scans that TBI caused substantial degeneration at the lesion site within a few weeks and these did not expand significantly thereafter. However, chronic alterations in neurons were observed, with reduced dendritic spine density lasting >1 year after injury. In parallel, we found a long-lasting inflammatory response throughout the entire brain. Deletion of one allele of CX3CR1, a chemokine receptor, limited infiltration of peripheral immune cells and largely prevented the chronic degeneration of the injured brain and provided a better functional recovery in female, but not male, mice. Therefore, targeting persistent neuroinflammation presents a new therapeutic option to reduce chronic neurodegeneration.SIGNIFICANCE STATEMENTTraumatic brain injury (TBI) often causes chronic neurological problems including epilepsy, neuropsychiatric disorders, and dementia through unknown mechanisms. Our study demonstrates that inflammatory cells invading the brain lead to secondary brain damage. Sex-specific amelioration of chronic neuroinflammation rescues the brain degeneration and results in improved motor functions. Therefore, this study pinpoints an effective therapeutic approach to preventing secondary complications after TBI.

31 July 2014 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
GLGemma Llovera
Gemma Llovera
SRStefan Roth
Stefan Roth
NPNikolaus Plesnila
Nikolaus Plesnila
RVRoland Veltkamp
Roland Veltkamp
ALArthur Liesz
Arthur Liesz
Stroke is the third most common cause of death and a main cause of acquired adult disability in developed countries. Only very limited therapeutical options are available for a small proportion of stroke patients in the acute phase. Current research is intensively searching for novel therapeutic strategies and is increasingly focusing on the sub-acute and chronic phase after stroke because more patients might be eligible for therapeutic interventions in a prolonged time window. These delayed mechanisms include important pathophysiological pathways such as post-stroke inflammation, angiogenesis, neuronal plasticity and regeneration. In order to analyze these mechanisms and to subsequently evaluate novel drug targets, experimental stroke models with clinical relevance, low mortality and high reproducibility are sought after. Moreover, mice are the smallest mammals in which a focal stroke lesion can be induced and for which a broad spectrum of transgenic models are available. Therefore, we describe here the mouse model of transcranial, permanent coagulation of the middle cerebral artery via electrocoagulation distal of the lenticulostriatal arteries, the so-called “coagulation model”. The resulting infarct in this model is located mainly in the cortex; the relative infarct volume in relation to brain size corresponds to the majority of human strokes. Moreover, the model fulfills the above-mentioned criteria of reproducibility and low mortality. In this video we demonstrate the surgical methods of stroke induction in the “coagulation model” and report histological and functional analysis tools.